A Phase 3, 12-month Treatment, Multicenter, Randomized, Open-Label, Parallel Group Clinical Trial Comparing Prandial Subcutaneous Insulin With Prandial Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
A Phase 3, 12-month Treatment, Multicenter, Randomized, Open-Label, Parallel Group Clinical Trial Comparing Prandial Subcutaneous Insulin With Prandial Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
The clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes mellitus and concurrent asthma.
Inclusion Criteria:
Exclusion Criteria:
Delegacion Cuauhtemoc, 6700, Mexico
Bialystock, POL 15-276, Poland
Lodz, 90-153, Poland
Yaroslavl, RUS 150003, Russia
Moscow, 105077, Russia
Moscow, 117 198, Russia
West Midlands, GBR B9 5SS, United Kingdom